MRI-identified multidimensional nodal features: predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma: LN feature-based nomogram for stage II NPC . (2022). Radiology and Oncology, 56(4), 479-487. https://www.ojstest.computing.si/index.php/ro/article/view/3963